Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1637-1642

  Baoum, Abdulgader A ^a   Berkland, Cory ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b University of Kansas   (United States)

Author keywords

A549 cells; Cell penetrating peptides; Gene delivery; Nanoparticles, stability, cytotoxicity; Plasmid DNA; Stability

Indexed keywords

ANTENNAPEDIA LEADER PEPTIDE; ANTENNAPEDIA PROTEIN; ARGININE; CALCIUM CHLORIDE; CELL PENETRATING PEPTIDE; NANOPARTICLE; PLASMID DNA; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CYTOTOXICITY; DRUG FORMULATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PARTICLE SIZE; PROTEIN STRUCTURE; ZETA POTENTIAL;

EID: 79952221839     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22407     Document Type: Article

References (48)

1. Luo D, Saltzman WM. 2000. Synthetic DNA delivery systems. Nat Biotechnol 18(1):33-37.
2. Ma H, Diamond SL. 2001. Nonviral gene therapy and its delivery systems. Curr Pharma Biotechnol 2(1):1-17.
3. Mahato RI, Smith LC, Rolland A. 1999. Pharmaceutical perspectives of nonviral gene therapy. Adv Genet 41:95-156.
4. Davis ME. 2002. Non-viral gene delivery systems. Curr Opin Biotechnol 13(2):128-131.
5. De Smedt SC, Demeester J, Hennink WE. 2000. Cationic polymer based gene delivery systems. Pharm Res 17(2):113-126.
6. Godbey WT, Mikos AG. 2001. Recent progress in gene delivery using non-viral transfer complexes. J Control Release 72(1-3):115-125.
7. Akinc A, Lynn DM, Anderson DG, Langer R. 2003. Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc 125(18):5316.
8. Brissault B, Kichler A, Guis C, Leborgne C, Danos O, Cheradame H. 2003. Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem 14(3):581-587.
9. Gebhart CL, Kabanov AV. 2001. Evaluation of polyplexes as gene transfer agents. J Control Release 73(2-3):401-416.
10. Godbey WT, Wu KK, Mikos AG. 1999. Poly (ethylenimine) and its role in gene delivery. J Control Release 60(2-3):149-160.
11. Hwang SJ, Bellocq NC, Davis ME. 2001. Effects of structure of [beta]-cyclodextrin-containing polymers on gene delivery. Bioconjug Chem 12(2):280-290.
12. Jeong JH, Song SH, Lim DW, Lee H, Park TG. 2001. DNA transfection using linear poly (ethylenimine) prepared by controlled acid hydrolysis of poly (2-ethyl-2-oxazoline). J Control Release 73(2-3):391-399.
13. Putnam D, Gentry CA, Pack DW, Langer R. 2001. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A 98(3):1200.
14. Reineke TM, Davis ME. 2003. Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type. Bioconjug Chem 14(1):255-261.
15. Reineke TM, Davis ME. 2003. Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers. Bioconjug Chem 14(1):247-254.
16. Zelikin AN, Putnam D, Shastri P, Langer R, Izumrudov VA. 2002. Aliphatic ionenes as gene delivery agents: Elucidation of structure-function relationship through modification of charge density and polymer length. Bioconjug Chem 13(3):548-553.
17. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. 1999. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16(8):1273-1279.
18. Forrest ML, Koerber JT, Pack DW. 2003. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem 14(5):934-940.
19. Duchardt F, Fotin-Mleczek M, Schwarz H, Fischer R, Brock R. 2007. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8(7):848-866.
20. Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SMV, Newham P, Lindsay MA. 2005. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 145(8):1093.
21. Meade BR, Dowdy SF. 2008. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 60(4-5):530-536.
22. Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Chernomordik LV. 2005. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280(15):15300.
23. Thorén PEG, Persson D, Isakson P, Goksör M, Önfelt A, Nordén B. 2003. Uptake of analogs of penetratin, Tat (48-60) and oligoarginine in live cells. Biochem Biophys Res Commun 307(1):100-107.
24. Tunnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. 2006. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 20(11):1775.
25. Zhang X, Jin Y, Plummer MR, Pooyan S, Gunaseelan S, Sinko PJ. 2009. Endocytosis and membrane potential are required for HeLa cell uptake of RI-CKTat9, a retro-inverso Tat cell penetrating peptide. Mol Pharm 6(3):836-848.
26. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 K i p 1 induces cell migration. Nat Med 4(12):1998-1912.
27. Tréhin R, Krauss U, Beck-Sickinger AG, Merkle HP, Nielsen HM. 2004. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat (47-57) through well-differentiated epithelial models. Pharm Res 21(7):1248-1256.
28. Rudolph C, Plank C, Lausier J, Schillinger U, Müller RH, Rosenecker J. 2003. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 278(13):11411.
29. Tung CH, Mueller S, Weissleder R. 2002. Novel branching membrane translocational peptide as gene delivery vector. Bioorg Med Chem 10(11):3609-3614.
30. Ellis-Behnke RG, Liang YX, You SW, Tay DKC, Zhang S, So KF, Schneider GE. 2006. Nano neuro knitting: Peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A 103(13):5054.
31. Papapostolou D, Smith AM, Atkins EDT, Oliver SJ, Ryadnov MG, Serpell LC, Woolfson DN. 2007. Engineering nanoscale order into a designed protein fiber. Proc Natl Acad Sci U S A 104(26):10853.
32. Silva GA, Czeisler C, Niece KL, Beniash E, Harrington DA, Kessler JA, Stupp SI. 2004. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303(5662):1352.
33. Woolfson DN, Ryadnov MG. 2006. Peptide-based fibrous biomaterials: Some things old, new and borrowed. Curr Opin Chem Biol 10(6):559-567.
34. Zhang S. 2003. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 21(10):1171-1178.
35. Heitz F, Morris MC, Divita G. 2009. Twenty years of cell penetrating peptides: From molecular mechanisms to therapeutics. Br J Pharmacol 157(2):195-206.
36. Saleh AFA, Aojula HS, Pluen A. 2008. Enhancement of gene transfer using YIGSR analog of Tat derived peptide. Biopolymers 89(1):62-71.
37. Soundara Manickam D, Bisht HS, Wan L, Mao G, Oupicky D. 2005. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J Control Release 102(1):293-306.
38. Midoux P, Monsigny M. 1999. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem 10(3):406-411.
39. Alexis F, Lo SL, Wang S. 2006. Covalent attachment of low molecular weight poly (ethylene imine) improves Tat peptide mediated gene delivery. Adv Mater 18(16):2174-2178.
40. Hyndman L, Lemoine JL, Huang L, Porteous DJ, Boyd AC, Nan X. 2004. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J Control Release 99(3):435-444.
41. Sloots A, Wels WS. 2005. Recombinant derivatives of the human high mobility group protein HMGB2 mediate efficient nonviral gene delivery. FEBS J 272(16):4221-4236.
42. McKenzie DL, Smiley E, Kwok KY, Rice KG. 2000. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug Chem 11(6):901-909.
43. Oupick D, Parker AL, Seymour LW. 2002. Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc 124(1):8-9.
44. Trubetskoy VS, Hanson LJ, Slattum PM, Hagstrom JE, Budker VG, Wolff JA. 1998. Self-assembly of DNA-polymer complexes using template polymerization. Nucleic Acids Res 26(18):4178.
45. Lo SL, Wang S. 2008. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29(15):2408-2414.
46. Dufourcq J, Neri W, Henry-Toulme N. 1998. Molecular assembling of DNA with amphipathic peptides. FEBS Lett 421(1):7-11.
47. Perry HAD, Alhaj Saleh AF, Aojula H, Pluen A. 2008. YOYO as a dye to track penetration of LK15 DNA complexes in spheroids: Use and limits. J Fluoresc 18(1):155-161.
48. Saleh AF, Aojula H, Arthanari Y, Offerman S, Alkotaji M, Pluen A. Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide. J Control Release 143(2):233-242.